REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Evaluation of the EU drug precursors regulations
1. This document presents the results of the evaluation of the EU’s two drug precursor trade regulations. The evaluation was conducted between 2017 and 2019, and assesses the implementation, effectiveness, efficiency, relevance, coherence and EU added value of the regulations (findings in paragraph 4). This report also covers the possible need for additional action to monitor and control suspicious transactions with non-scheduled substances.
2. Drug precursors are chemicals which have legitimate uses, such as in the production of pharmaceuticals, cosmetics and perfumes, but can also be used in the illicit manufacture of narcotic drugs and psychotropic substances. Criminals will may attempt to divert these chemicals from legitimate trade for use in the manufacture of illicit drugs.
3. Drug precursors are controlled at an international level under the 1988 UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which contains provisions to prevent the diversion of substances often used in the illicit manufacture of drugs. They are also scheduled in EU legislation, providing regulations for intra-EU trade, and trade between an EU Member State and third country. UK legislation will provide the legal basis for Great Britain’s (GB) drug precursor trade regulations following the end of the transition period, while Northern Ireland will continue to apply EU regulations.
|Topic||Justice & Home Affairs|